Cargando…
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future
BACKGROUND: Risk sharing schemes represent an innovative and important approach to the problems of rationing and achieving cost-effectiveness in high cost or controversial health interventions. This study aimed to assess the feasibility of risk sharing schemes, looking at long term clinical outcomes...
Autores principales: | Pickin, Mark, Cooper, Cindy L, Chater, Timothy, O'Hagan, Anthony, Abrams, Keith R, Cooper, Nicola J, Boggild, Mike, Palace, Jackie, Ebers, George, Chilcott, James B, Tappenden, Paul, Nicholl, Jon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631506/ https://www.ncbi.nlm.nih.gov/pubmed/19126193 http://dx.doi.org/10.1186/1471-2377-9-1 |
Ejemplares similares
-
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator
por: Boggild, Mike, et al.
Publicado: (2009) -
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
por: Palace, Jacqueline, et al.
Publicado: (2014) -
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
por: Palace, Jacqueline, et al.
Publicado: (2019) -
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006) -
Multiple sclerosis: major histocompatibility complexity and antigen presentation
por: Ramagopalan, Sreeram V, et al.
Publicado: (2009)